According to SurgePays's latest financial reports and stock price the company's current Operating Margin is 3.87%. At the end of 2022 the company had an Operating Margin of -0.46%.
Year | Operating Margin | Change |
---|---|---|
2022 | -0.46% | -98.28% |
2021 | -26.50% | 34.47% |
2020 | -19.71% | -39.94% |
2019 | -32.81% | 242.88% |
2018 | -9.57% | -93.09% |
2017 | -138.49% | -0.75% |
2016 | -139.54% | 195.85% |
2015 | -47.16% | -3888.12% |
2014 | 1.25% | -100.03% |
2013 | -4,292.76% | -86.21% |
2012 | -31,133.67% | 301.39% |
2011 | -7,756.53% | 25.24% |
2010 | -6,193.10% | -49.16% |
2009 | -12,180.55% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 22.88% | 491.21% | ๐บ๐ธ USA |
Novartis NVS | 17.27% | 346.25% | ๐จ๐ญ Switzerland |
Stryker Corporation SYK | 16.21% | 318.86% | ๐บ๐ธ USA |
Cooper Companies COO | 14.36% | 271.06% | ๐บ๐ธ USA |
STAAR Surgical STAA | 16.10% | 316.02% | ๐บ๐ธ USA |
CONMED CNMD | -6.77% | -274.94% | ๐บ๐ธ USA |
Integra LifeSciences IART | 13.73% | 254.78% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.